Dr. Zhao Luyang, the founder of Salus Biomed, has been leading the company as CEO with over a decade of expertise in biotech innovation and management. He was a senior analyst in GTJA Investment Group, responsible for the company’s investment research and strategic planning in biotechnical areas. Before shifting to investment, Dr. Zhao was the Director of the Chemistry Department at a biotech company, leading the development of chemistry.
Dr. Zhao holds a PhD in analytical chemistry from North Carolina State University and received an honorary degree along with his Bachelor degree from the University of Science and Technology of China.
Prof. Wang Gufeng, a co-founder of Salus BioMed, contributes over 20 years of expertise in surface chemistry and optical imaging. As a former professor at North Carolina State University's Chemistry Department, Prof. Wang pioneered innovations in super-resolution optical imaging technologies for structural observation of subcellular organelles and dynamic tracking of biomolecular trafficking during his time at NCSU. He also worked on developing ultra-fast, ultra-sensitive, high-plex assays for cancer diagnostic and prognostic markers.
Prof. Wang holds his PhD from the University of Iowa in analytical chemistry and received his postdoctoral training from Profs. Edward S Yeung and Ning Fang at Ames Lab, US DOE and Iowa State University. Over his 20 years of work in science and discovery, Prof. Wang has published over 80 peer-reviewed papers in high-profile scientific journals, including Nature, Nature Cell Biol., J.Am. Chem. Soc., Angewandte. Chemie, etc.
info@salus-bio.com
+86 0755-2374583220/F, BLK1, Hengtaiyu Research Park, Shenzhen, Guangdong, P.R. China